|
1N0W
Crystal structure of a RAD51-BRCA2 BRC repeat complex
Deposited 2002-10-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
1517–1551(35 aa)
Fragment:BRC repeat type 4
|
Not recorded
|
MG MAGNESIUM ION × 1
CL CHLORIDE ION × 1
EDO 1,2-ETHANEDIOL × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.2;291 K;ETHYLENE GLYCOL, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 1.70 Å
R-free 0.206
|
|
3EU7
Crystal Structure of a PALB2 / BRCA2 complex
Deposited 2008-10-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain X
21–39(19 aa)
Fragment:Interaction with PALB2, residues 21-39
|
Not recorded
|
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1M Na-Cacodylate pH 6.5, 0.2M magnesium acetate, 10% (w/v) PEG 8000, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.20 Å
R-free 0.253
|
|
7BDX
Armadillo domain of HSF2BP in complex with BRCA2 peptide
Deposited 2020-12-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain E
2291–2343(53 aa)
Chain F
2291–2343(53 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;PEG 3350 : 16% (w/v)
Mes ph 6.0 100 mM
MgCl2 100 mM
|
Resolution 2.60 Å
R-free 0.241
|
|
8BR9
Stapled peptide SP24 in complex with humanised RadA mutant HumRadA22
Deposited 2022-11-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1226–1263(38 aa)
|
Not recorded
|
ADP ADENOSINE-5'-DIPHOSPHATE × 1
RF6 4,6-diethylpyrimidin-2-amine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291.15 K;0.1 M Na 3 Cit 4.2 pH (Buffer)
20 %w/v PEG 1K
(Precipitant)
0.2 M Li 2 SO4 (Salt)
|
Resolution 1.63 Å
R-free 0.282
|
|
8C3J
Stapled peptide SP2 in complex with humanised RadA mutant HumRadA22
Deposited 2022-12-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1226–1244(19 aa)
Chain C
2050–2064(15 aa)
|
Not recorded
|
TKI 2-[(4,6-diethyl-1,3,5-triazin-2-yl)-methyl-amino]ethanoic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Protein in 20 mM CHES pH 9.5, 100
mM NaCl.
Condition: 8 % w/v PEG 8000
(precipitant) 0.08 M
Potassium phosphate pH
5.6 (buffer)
200:200 uL drop
|
Resolution 3.02 Å
R-free 0.281
|
|
8C3J
Stapled peptide SP2 in complex with humanised RadA mutant HumRadA22
Deposited 2022-12-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain J
1226–1244(19 aa)
Chain J
2050–2064(15 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Protein in 20 mM CHES pH 9.5, 100
mM NaCl.
Condition: 8 % w/v PEG 8000
(precipitant) 0.08 M
Potassium phosphate pH
5.6 (buffer)
200:200 uL drop
|
Resolution 3.02 Å
R-free 0.281
|
|
8C3N
Stapled peptide SP30 in complex with humanised RadA mutant HumRadA22
Deposited 2022-12-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1215–1243(29 aa)
|
Not recorded
|
ADP ADENOSINE-5'-DIPHOSPHATE × 1
MG MAGNESIUM ION × 1
RF6 4,6-diethylpyrimidin-2-amine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Protein: 0.5 mM SP30:HumRadA22 in 20 mM CHES pH 9.5, 100 mM NaCl, 20 mM ADP/MgCl 2
Condition:
14% w/v PEG 4000
(precipitant), 6% v/v MPD
(precipitant), 0.1M Na K
Phos pH 6.2 (buffer)
|
Resolution 1.21 Å
R-free 0.218
|
|
8PBC
RAD51 filament on ssDNA bound by the BRCA2 c-terminus
Deposited 2023-06-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 21
PDB declaration: 22-meric
|
Chain L
3260–3308(49 aa)
Chain M
3260–3308(49 aa)
Chain N
3260–3308(49 aa)
Chain O
3260–3308(49 aa)
Chain P
3260–3308(49 aa)
Chain Q
3260–3308(49 aa)
Chain R
3260–3308(49 aa)
Chain S
3260–3308(49 aa)
Chain T
3260–3308(49 aa)
Chain U
3260–3308(49 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 11
CA CALCIUM ION × 22
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.61 Å
|
|
8PBD
RAD51 filament on dsDNA bound by the BRCA2 c-terminus
Deposited 2023-06-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 19
PDB declaration: 21-meric
|
Chain K
3260–3308(49 aa)
Chain L
3260–3308(49 aa)
Chain M
3260–3308(49 aa)
Chain N
3260–3308(49 aa)
Chain O
3260–3308(49 aa)
Chain P
3260–3308(49 aa)
Chain Q
3260–3308(49 aa)
Chain R
3260–3308(49 aa)
Chain S
3260–3308(49 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 10
CA CALCIUM ION × 20
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.83 Å
|
|
8QQE
Crystal structure of the complex between DMC1 and the PhePP domain of BRCA2
Deposited 2023-10-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 16
PDB declaration: hexadecameric
|
Chain C
2398–2417(20 aa)
Chain D
2398–2417(20 aa)
|
Not recorded
|
MG MAGNESIUM ION × 4
CL CHLORIDE ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6;293 K;0.1M MES at pH 6, 2.4 M sodium formate
|
Resolution 3.46 Å
R-free 0.261
|
|
8R2G
Crystal structure of a BRCA2-DMC1 complex
Deposited 2023-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 15
PDB declaration: pentadecameric
|
Chain I
2400–2413(14 aa)
Chain J
2400–2413(14 aa)
Chain K
2400–2413(14 aa)
Chain L
2400–2413(14 aa)
Chain M
2400–2413(14 aa)
Chain N
2400–2413(14 aa)
Chain O
2400–2413(14 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;50 mM HEPES-NaOH pH 7.4, 50 mM MgCl2, 500 mM NaCl, 8 % PEG 3350, 20 % glycerol
|
Resolution 3.45 Å
R-free 0.306
|
|
8UVW
Crystal structure of RAD51-BRCA2 Cter complex
Deposited 2023-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
1517–1547(31 aa)
Chain D
3270–3305(36 aa)
|
Mutation:C319S
Mutation:S208E,A209D,C3287A,C3304A,C391S
|
ADP ADENOSINE-5'-DIPHOSPHATE × 2
BEF BERYLLIUM TRIFLUORIDE ION × 2
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;25% v/v 1,4-Dioxane
0.05 M MOPS pH 7.0
0.005 M Magnesium chloride hexahydrate
0.001 M Spermine
|
Resolution 2.73 Å
R-free 0.282
|